Baculovirus expression and potential diagnostic application of the gp51 envelope glycoprotein of genetic mutants of the bovine leukaemia virus

Open access


Introduction: Field isolates of bovine leukaemia virus (BLV) show the presence of a few amino acid substitutions in major conformational G and H epitopes on surface glycoprotein gp51. Potentially, these substitutions can affect the 3D structure of these epitopes leading to their diminished immunoreactivity. The aim of this study was to express three gp51 glycoproteins carrying mutated epitopes as recombinant baculovirus proteins in insect cells to test their immunoreactivity with bovine sera.

Material and Methods: Env gene chimeras encoding mutated epitopes G and H in the env backbone of BLV FLK strain were constructed, cloned into pFastBac1 vector, and expressed in baculovirus.

Results: The presence of recombinant gp51 protein in Sf9 insect cells was confirmed using monoclonal antibodies. ELISA tests were developed to check the immunoreactivity of recombinant protein with bovine sera.

Conclusion: Recombinant gp51 proteins with altered G and H epitopes can be used for further studies to analyse the serological response of bovine sera towards BLV antigenic variants.

1. Bicka L., Rola M., Kozaczyńska B., Stec J., Kuźmak J.: Characteristics of genetic mutants of bovine leukaemia virus and their role in serodiagnosing BLV infections. Med Weter 2005, 61, 699–702.

2. Bruck C., Portetelle D., Burny A., Zavada J.: Topographical analysis by monoclonal antibodies of BLV-gp51 epitopes involved in viral functions. Virology 1982, 122, 353–362.

3. Bruck C., Mathot S., Portetelle D., Berte C., Franssen J.D., Herion P., Burny A.: Monoclonal antibodies define eight independent antigenic regions on the bovine leukemia virus (BLV) envelope glycoprotein gp51. Virology 1982, 122, 342–352.

4. Bruck C., Rensonnet N., Portetelle D., Cleuter Y., Mammerickx M., Burny A., Mamoun R., Guillemain B., Van der Maaten M.J., Ghysdael J.: Biologically active epitopes of bovine leukemia virus glycoprotein gp51: their dependence on protein glycosylation and genetic variability. Virology 1984, 136, 20–31.

5. De Giuseppe A., Feliziani F., Rutili D., De Mia G.M.: Expression of the bovine leukemia virus envelope glycoprotein (gp51) by recombinant baculovirus and its use in an enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol 2004, 11, 147–151.

6. Forti K., Rizzo G., Cagiola M., Ferrante G., Marini C., Feliziani F., Pezzotti G., De Giuseppe A.: Identification of a novel overlapping sequential E epitope (E’) on the bovine leukaemia virus SU glycoprotein and analysis of immunological data. Vet Microbiol 2014, 172, 157–167.

7. Gillet N., Florins A., Boxus M., Burteau C., Nigro A., Vandermeers F., Balon H., Bouzar A., Defoiche J, Burny A, Reichert M, Kettmann R, Willems L.: Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human. Retrovirology 2007, 16, 4–18.

8. Johnston E., Albritton L., Radke K.: Envelope proteins containing single amino acid substitutions support a structural model of the receptor - binding domain of bovine leukemia virus. J Virol 2002, 76, 10861–10872.

9. Lavanya M., Kinet S., Montel-Hagen A., Mongelaz C., Battini J.L., Taylor N.: Cell surface expression of the bovine leukemia virus-binding receptor on B and T lymphocytes is induced by receptor engagement. J Immunol 2008, 181, 891–898.

10. Lee E., Kim E.J., Ratthanophart J., Vitoonpong R., Kim B.H., Cho I.S., Song J.Y., Lee K.K, Shin Y.K.: Molecular epidemiological and serological studies of bovine leukemia virus (BLV) infection in Thailand cattle. Infect Genet Evol 2016, 41, 245–254.

11. Mamoun R.Z., Morrison M., Rebeyrotte N., Busetta B., Couez D., Kettmann R., Hospital M., Guillemain B.: Sequence variability of bovine leukemia virus env gene and its relevance to the structure and antigenicity of the glycoproteins. J Virol 1990, 64, 4180–4188.

12. Pluta A., Rola-Łuszczak M., Kubiś P., Balov S., Moskalik R., Choudhury B., Kuźmak J.: Molecular characterization of bovine leukemia virus from Moldovan dairy cattle. Arch Virol 2017, 162, 1563–1576.

13. Polat M., Moe H.H, Shimogiri T., Moe K.K., Takeshima S.N, Aida Y.: The molecular epidemiological study of bovine leukemia virus infection in Myanmar cattle. Arch Virol 2017, 162, 425–437.

14. Portetelle D., Dandoy C., Burny A., Zavada J., Siakkou H., Geas-Masse H., Drobecq H., Tartar A.: Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51. Virology 1989, 169, 34–41.

15. Rola-Łuszczak M., Pluta A., Olech M., Donnik I., Petropavlovskiy M., Gerilovych A., Vinogradova I., Choudhury B., Kuźmak J.: The molecular characterization of bovine leukaemia virus isolates from Eastern Europe and Siberia and its impact on phylogeny. PLoS One 2013, 8, e58705. Doi: 10.1371/journal.pone.0058705.

16. Tallet B., Astier-Gin T., Moynet D., Londos-Gagliardi D., Guillemain B.: Sequence variations in the amino- and carboxyterminal parts of the surface envelope glycoprotein of HTLV type 1 induce specific neutralizing antibodies. AIDS Res Human Retroviruses 2001, 17, 337–348.

17. Zhao X., Buehring G.C.: Natural genetic variations in bovine leukemia virus envelope gene: Possible effects of selection and escape. Virology 2007, 366, 150–165.

Journal of Veterinary Research

formerly Bulletin of the Veterinary Institute in Pulawy

Journal Information

IMPACT FACTOR J Vet Res 2017: 0.811

CiteScore 2017: 0.68

SCImago Journal Rank (SJR) 2017: 0.29
Source Normalized Impact per Paper (SNIP) 2017: 0.484


All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 243 243 157
PDF Downloads 145 145 74